General Information of the Compound
| Compound ID |
CP0035071
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
3-methoxy-9-(3-methoxy-4-nitrophenyl)-2-(2-pyridin-4-ylethyl)-5,11-dihydrobenzo[b][1,4]benzodiazepin-6-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C28H24N4O5
|
||||||||||||||||||
| Molecular Weight |
496.523
|
||||||||||||||||||
| Canonical SMILES |
COc1cc2NC(=O)c3ccc(cc3Nc2cc1CCc1ccncc1)-c1ccc(c(OC)c1)[N+]([O-])=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C28H24N4O5/c1-36-26-16-24-23(14-20(26)4-3-17-9-11-29-12-10-17)30-22-13-18(5-7-21(22)28(33)31-24)19-6-8-25(32(34)35)27(15-19)37-2/h5-16,30H,3-4H2,1-2H3,(H,31,33)
Show/Hide
|
||||||||||||||||||
| InChIKey |
CKTLWCQCWAQUSF-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00865, Serine/threonine-protein kinase Chk1
Cell Viability or Cytotoxicity Assay
| Cell Line ID | Cell Line Name | Cell Line Organism | |
| CL000017 | HeLa | Homo sapiens (Human) | 1 |
| 1 |
EC50 = 9600 nM
|
TI
LI
LO
TS
|
|
|---|---|---|---|